Loading company
Drugs Made In America Acquisition Corp.
DMAA · Nasdaq · ·
$10.85+0.1%Sep 28 close
- 1M
- +0.9%
- 6M
- +3.5%
- 1Y
- +5.6%
Trailing twelve months where a flow is involved, latest reported balance where it is not.
Both on one scale, because both are money — the bar that is taller is the one that matters.
Cash counts short-term investments, not just the bank balance — technology companies park most of it in marketable securities, and leaving those out understates it several times over. Debt includes lease obligations.
Only the three costs filers report consistently. Anything a company does not break out sits outside these bands, so the stack is not the whole cost base.
Not on the overview because five charts is as much as one decision needs — but here in full, on one period switch. Each bar sums the four quarters ending there — a full year, brought up to today.
$6.09MQ2 2026-8.4%
What was left after every cost, including tax. Each bar sums the four quarters ending there — a full year, brought up to today.
Everything above comes from Drugs Made In America Acquisition Corp.’s own filings with the SEC, as reported. No estimates, no analyst figures, nothing adjusted.
Not reported by this filer: Total Revenue, Cost of Revenue, Gross Profit, R&D Expense, Total Operating Expenses, Interest Expense, Income Tax Expense, Profit per share, Shares outstanding, Interest Income, Net Interest Income, Non-interest Income, Non-interest Expense, Provision for Credit Losses, Loans, Short-term Investments, Inventory, Receivables, Long-term Debt (noncurrent), Short-term Borrowings, Borrowings (total), Operating Lease (current), Operating Lease (noncurrent), Operating Lease (total), Finance Lease (current), Finance Lease Liabilities (total), Finance Lease (noncurrent), Capital Expenditures, Dividends paid, Stock-Based Compensation, Depreciation & Amortization, Depreciation, Amortization of Intangibles, and Share Repurchases. Companies choose which XBRL tags to use, and anything untagged cannot be recovered — so these are blank rather than guessed.
DMAA · Nasdaq · ·
$10.85+0.1%Sep 28 close